Microbiological profile of respiratory tract infections in children with neurological impairment
DOI:
https://doi.org/10.33448/rsd-v13i9.46824Keywords:
Child; Microbiology; Pneumonia, Bacterial; Nervous system diseases.Abstract
The microbiological profile of respiratory infections in children with neurological impairment (CNI) may differ from that of the general population, which is why this study is interested in investigating the main bacterial agents that affect the respiratory tract of CNI compared to the general compared to the general pediatric population. To this end, the aim of this article is to present a systematic review of the microbiological profile of respiratory tract infections in children with neurological impairment. Initially found 34 articles in the Pubmed, Cochrane and BvSalud databases, published between 2014 and 2024. Of these, articles covering bacterial pneumonia were included, and review articles without meta-analysis were excluded, master's dissertations and doctoral theses that did not contain an observational study; a total of 5 articles were used. The The main causative agents of bacterial pneumonia vary according to the child's age and condition of the child, with Pseudomonas aeruginosa and Staphylococcus aureus predominate in CNI, unlike other children, in whom commonly develop pneumonia due to Streptococcus pneumoniae and, less commonly, Staphylococcus aureus. The microbiological profile of respiratory infections in children with neurological syndromes differs from that of the general population due to their susceptibility to atypical and sometimes more severe infections. However, more studies are needed on this subject clarification is needed in the current literature.
References
Bodey, G. P., Jadeja, L., & Elting, L. (1985). Pseudomonas bacteremia: retrospective analysis of 410 episodes. Archives of internal medicine, 145(9), 1621-1629.
Broughton, R. A. (1986). Infections due toMycoplasma pneumoniaein childhood. The Pediatric infectious disease journal, 5(1), 71-85.
Banerjee, R., Barnett, E. D., Lynfield, R., Sawyer, M. H. (2024). Streptococcus pneumoniae (pneumococcal) infections. American Academy of Pediatrics & Committee on Infectious Diseases. Red book: 2024-2027 report of the Committee on Infectious Diseases, 33ª Ed. American Academy of Pediatrics, p. 810.
Carter, M. J., Gurung, M., Pokhrel, B., Bijukchhe, S. M., Karmacharya, S., Khadka, B., & Pollard, A. J. (2022). Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005–2013). The Pediatric infectious disease journal, 41(3), 192-198.
Crabtree, T. D., Gleason, T. G., Pruett, T. L., & Sawyer, R. G. (1999). Trends in nosocomial pneumonia in surgical patients as we approach the 21st century: a prospective analysis. The American Surgeon, 65(8), 706-710.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Artes médicas.
Green, E. W., Ndiaye, M., Hossain, I. M., Olatunji, Y. A., Sahito, S. M., Salaudeen, R., & Mackenzie, G. A. (2023). Pneumonia, meningitis, and Septicemia in adults and older children in rural Gambia: 8 years of population-based surveillance. Clinical Infectious Diseases, 76(4), 694-703.
Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M., & Thomson, A. (2002). British Thoracic Society guidelines for the management of community acquired pneumonia in children. Thorax, 57(Suppl 1), i1-e24.
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., & Finelli, L. (2015). Community-acquired pneumonia requiring hospitalization among US adults. New England Journal of Medicine, 373(5), 415-427.
Mpabalwani, E. M., Lukwesa-Musyani, C., Imamba, A., Nakazwe, R., Matapo, B., Muzongwe, C. M., ... & Lessa, F. C. (2019). Declines in pneumonia and meningitis hospitalizations in children under 5 years of age after introduction of 10-valent pneumococcal conjugate vaccine in Zambia, 2010–2016. Clinical Infectious Diseases, 69(Supplement_2), S58-S65.
McIntosh, K. (2002). Community-acquired pneumonia in children. New England Journal of Medicine, 346(6), 429-437.
Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Lexau, C., Bennett, N. M., & Whitney, C. G. (2015). Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. The Lancet Infectious Diseases, 15(3), 301-309.
Moise, P. A., Gonzalez, M., Alekseeva, I., Lopez, D., Akrich, B., DeRyke, C. A., & Motyl, M. (2021). Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU. JAC-Antimicrobial Resistance, 3(1), dlaa129.
Olarte, L., Barson, W. J., Barson, R. M., Romero, J. R., Bradley, J. S., Tan, T. Q., & Kaplan, S. L. (2017). Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era. Clinical Infectious Diseases, 64(12), 1699-1704.
Organização Mundial Da Saúde (2024). Base de dados de mortalidade da OMS: infecções respiratórias inferiores de 2020 a 2022. https://platform.who.int/mortality/themes/theme-details/topics/indicator-groups/indicator-group-details/MDB/lower-respiratory-infections
Ouldali, N., Levy, C., Minodier, P., Morin, L., Biscardi, S., Aurel, M., & Cohen, R. (2019). Long-term association of 13-valent pneumococcal conjugate vaccine implementation with rates of community-acquired pneumonia in children. JAMA pediatrics, 173(4), 362-370.
Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & Group, T. S. P. (1998). Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrobial agents and chemotherapy, 42(7), 1762-1770.
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999). Nosocomial infections in medical intensive care units in the United States. Critical care medicine, 27(5), 887-892.
Slekovec, C., Robert, J., van der Mee-Marquet, N., Berthelot, P., Rogues, A. M., Derouin, V., & Bertrand, X. (2019). Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012–2013 study. European Journal of Clinical Microbiology & Infectious Diseases, 38, 921-926.
Thomson, J., Hall, M., Ambroggio, L., Berry, J. G., Stone, B., Srivastava, R., & Shah, S. S. (2020). Antibiotics for aspiration pneumonia in neurologically impaired children. Journal of Hospital Medicine, 15(7), 395-402.
Tipple, M. A., Beem, M. O., & Saxon, E. M. (1979). Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics, 63(2), 192-197.
Warniment, A., Steuart, R., Rodean, J., Hall, M., Chinchilla, S., Shah, S. S., & Thomson, J. (2021). Variation in bacterial respiratory culture results in children with neurologic impairment. Hospital Pediatrics, 11(11), e326-e333.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ray Braga Romero; Ana Laura Rezende Costa; Dalila Morais Vilela; Mariana Sanches de Carvalho; Renato Alves Nunes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
